{"id":981851,"date":"2026-07-15T10:10:36","date_gmt":"2026-07-15T14:10:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/"},"modified":"2026-07-15T10:10:36","modified_gmt":"2026-07-15T14:10:36","slug":"ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/","title":{"rendered":"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">MONSEY, N.Y., July  15, 2026  (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Cross Country Healthcare (Nasdaq: CCRN) (\u201cCCRN\u201d) for $13.25 per share in cash to Knox Lane, a private equity firm.<\/p>\n<p>Wohl &amp; Fruchter originally launched its investigation because CCRN had previously reached an agreement in December 2024 to be acquired by Aya Healthcare for $18.61 per share in cash. That agreement was terminated in December 2025 due to regulatory delays arising from the government shutdown. Then just five months later, on May 6, 2026, CCRN announced the proposed sale to Knox Lane for $13.25 per share in cash\u2014nearly 29% lower than the price offered by Aya.<\/p>\n<p>Additionally, on March 5, 2026, a Benchmark analyst raised Cross Country\u2019s target price to $14.00 per share based on Cross Country\u2019s \u201csolidly improving outlook,\u201d and \u201cpath to improving EBITDA margins.\u201d Thereafter, on March 19, 2026, a Wedbush analyst raised Cross Country\u2019s target price to $15.00 per share \u201cfollowing a management meeting that increased [his] conviction in the \u2018timing and achievability\u2019 of the company\u2019s revenue stabilization expectations, profitability recovery and tech-enabled strategic pivot.\u201d<\/p>\n<p>Wohl &amp; Fruchter has renewed its investigation of the proposed sale after further review of the definitive proxy filed by CCRN with the SEC on June 15, 2026, soliciting CCRN stockholders to approve the proposed sale at a vote presently scheduled for July 16, 2026.<\/p>\n<p>\n        <strong>If you remain a CCRN shareholder and have concerns about the fairness of the sale price, you may contact our firm at the following link to discuss your legal rights at no charge: <\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2Xlxi66MyVbJTZRNk3_9W3r4E7WOpnWr1ZmfZb-UjSZfSvF5Uz2vhjx5YKsfi4lnXIitMGPG9C9gt5Fd93UIo-xpgqvGwY7SMlp3SmC3cgqqwdCWe60nQUUtgrcYPyj9mXeHNLFn2rUp8EJ55DJdhYlwof5Fzswgn0OyR1Lt-fpVugyI4JJBO52o4dFm6UXi\" rel=\"nofollow\" target=\"_blank\">https:\/\/wohlfruchter.com\/cases\/cross-country-healthcare\/<\/a>\n      <\/p>\n<p>Alternatively, you may contact us by phone at 866-833-6245, or via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VW9Euf7wCoyGOSflcXvVEUqdlKxbwlaj5eCSWLsN65fK3LTrSSsahXE98zY-980MOYla69YoEM1x8bFxQyL0j8jCyNVKl7HE-KHSQ4uv2YA=\" rel=\"nofollow\" target=\"_blank\">alerts@wohlfruchter.com<\/a>.<\/p>\n<p>\u201cWe are investigating whether the CCRN board of directors acted in the best interests of CCRN shareholders in recommending the sale,\u201d explained Joshua Fruchter, a founding partner of Wohl &amp; Fruchter. \u201cThis includes whether the sale price is fair to CCRN shareholders, and whether all material information regarding the transaction has been fully disclosed. We encourage CCRN shareholders to contact the firm if they have any concerns.\u201d<\/p>\n<p>\n        <strong>About Wohl &amp; Fruchter <\/strong>\n      <\/p>\n<p>Wohl &amp; Fruchter LLP has for over a decade been representing investors in litigation arising from fraud and other corporate misconduct, and recovered hundreds of millions of dollars in damages for investors. Please visit our website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_ykUEcB9028Z726hTd6kIbKnpgV_UNW_m2qC3L2B0vrPeZwUuIX1eP4WCIuOT-5_6_b3B5zQcAWO7e6wZwEIe9QcYCMTPv8IdsTCkeareJY=\" rel=\"nofollow\" target=\"_blank\">www.wohlfruchter.com<\/a>, to learn more about our Firm, or contact one of our partners.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Wohl &amp; Fruchter LLP<br \/>Joshua E. Fruchter <br \/>Toll Free 866.833.6245<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VW9Euf7wCoyGOSflcXvVEUqdlKxbwlaj5eCSWLsN65dNZ35a9ug5tF-E_2TsjDERynp0joMbHoRD3AElR_2Avi6g_-_lkG324uMJWVQGW2nzV7_-u7sbGpmZAsgRb1iR\" rel=\"nofollow\" target=\"_blank\">alerts@wohlfruchter.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_ykUEcB9028Z726hTd6kIbKnpgV_UNW_m2qC3L2B0vpMbL1Nkm7wD6Ti24F5WN9V0FpacbUobPqnHsUBhVBAtcieFjQuPTS-L0KXcM1nT1A=\" rel=\"nofollow\" target=\"_blank\">www.wohlfruchter.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGYyM2IxZjgtYzE3MS00YTY2LThlMWYtZDg1ODc2ODE3MDUxLTEyNDQ4MzAtMjAyNi0wNy0xNS1lbg==\/tiny\/Wohl-Fruchter-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MONSEY, N.Y., July 15, 2026 (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Cross Country Healthcare (Nasdaq: CCRN) (\u201cCCRN\u201d) for $13.25 per share in cash to Knox Lane, a private equity firm. Wohl &amp; Fruchter originally launched its investigation because CCRN had previously reached an agreement in December 2024 to be acquired by Aya Healthcare for $18.61 per share in cash. That agreement was terminated in December 2025 due to regulatory delays arising from the government shutdown. Then just five months later, on May 6, 2026, CCRN announced the proposed sale to Knox Lane for $13.25 per share in cash\u2014nearly 29% lower than the price &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-981851","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MONSEY, N.Y., July 15, 2026 (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Cross Country Healthcare (Nasdaq: CCRN) (\u201cCCRN\u201d) for $13.25 per share in cash to Knox Lane, a private equity firm. Wohl &amp; Fruchter originally launched its investigation because CCRN had previously reached an agreement in December 2024 to be acquired by Aya Healthcare for $18.61 per share in cash. That agreement was terminated in December 2025 due to regulatory delays arising from the government shutdown. Then just five months later, on May 6, 2026, CCRN announced the proposed sale to Knox Lane for $13.25 per share in cash\u2014nearly 29% lower than the price &hellip; Continue reading &quot;CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-15T14:10:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0\",\"datePublished\":\"2026-07-15T14:10:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/\"},\"wordCount\":439,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/\",\"name\":\"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=\",\"datePublished\":\"2026-07-15T14:10:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/","og_locale":"en_US","og_type":"article","og_title":"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0 - Market Newsdesk","og_description":"MONSEY, N.Y., July 15, 2026 (GLOBE NEWSWIRE) &#8212; The law firm of Wohl &amp; Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Cross Country Healthcare (Nasdaq: CCRN) (\u201cCCRN\u201d) for $13.25 per share in cash to Knox Lane, a private equity firm. Wohl &amp; Fruchter originally launched its investigation because CCRN had previously reached an agreement in December 2024 to be acquired by Aya Healthcare for $18.61 per share in cash. That agreement was terminated in December 2025 due to regulatory delays arising from the government shutdown. Then just five months later, on May 6, 2026, CCRN announced the proposed sale to Knox Lane for $13.25 per share in cash\u2014nearly 29% lower than the price &hellip; Continue reading \"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-15T14:10:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0","datePublished":"2026-07-15T14:10:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/"},"wordCount":439,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/","name":"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=","datePublished":"2026-07-15T14:10:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjU3NyM3NzA3MjU0IzIyMzMyNzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ccrn-alert-monsey-firm-of-wohl-fruchter-renews-investigation-of-the-proposed-sale-of-cross-country-healthcare-to-knox-lane\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CCRN Alert: Monsey Firm of Wohl &amp; Fruchter Renews Investigation of the Proposed Sale of Cross Country Healthcare to Knox Lane\u00a0\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=981851"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981851\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=981851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=981851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=981851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}